-transparent.png){kind=logo}
Infusions of group B streptococci cause pulmonary hypertension in several neonatal animal models. A continuous infusion of prostaglandin D2 reduced the magnitude of this pulmonary hypertensive response; indomethacin completely blocked the response. Prostaglandin D2 or cyclooxygenase inhibitors may be important therapeutic agents for infants with group B streptococcal sepsis who manifest pulmonary hypertension.
Related Publications
K W Huddleston, and
R K Lyrene, and
A Dew, and
B M Gray, and
J B Philips
June 1983,
Journal of applied physiology: respiratory, environmental and exercise physiology,
K W Huddleston, and
R K Lyrene, and
A Dew, and
B M Gray, and
J B Philips
January 1978,
Advances in prostaglandin and thromboxane research,
K W Huddleston, and
R K Lyrene, and
A Dew, and
B M Gray, and
J B Philips
February 1992,
Pediatric research,
K W Huddleston, and
R K Lyrene, and
A Dew, and
B M Gray, and
J B Philips
April 1993,
Pediatric research,
K W Huddleston, and
R K Lyrene, and
A Dew, and
B M Gray, and
J B Philips
June 2006,
Clinical evidence,
K W Huddleston, and
R K Lyrene, and
A Dew, and
B M Gray, and
J B Philips
January 2008,
BMJ clinical evidence,
K W Huddleston, and
R K Lyrene, and
A Dew, and
B M Gray, and
J B Philips
February 2014,
BMJ clinical evidence,
K W Huddleston, and
R K Lyrene, and
A Dew, and
B M Gray, and
J B Philips
February 2024,
Pediatrics in review,
K W Huddleston, and
R K Lyrene, and
A Dew, and
B M Gray, and
J B Philips
September 2010,
BMJ clinical evidence,
K W Huddleston, and
R K Lyrene, and
A Dew, and
B M Gray, and
J B Philips
May 1992,
Archives francaises de pediatrie,
